Loading
companiesCompany
Takeda Ventures
Takeda Ventures, founded in 2001, is Takeda's corporate venture group, investing in preclinical, platform-based drug companies whose programmes complement Takeda's pipeline in oncology, rare genetics and haematology, neuroscience and gastrointestinal disease. Its page lists no portfolio companies, so no cancer examples are recorded here.
Overview
Takeda's Center for External Innovation page states: 'Takeda Ventures, Inc. is the corporate venture capital group of Takeda, and was founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments.' It 'focuses on high-caliber, therapeutic, platform-based companies around the world', specifically 'early-stage, preclinical opportunities and products which complement Takeda's pipeline', and partners with academic innovators, entrepreneurs and venture investors 'to create and nurture a portfolio of companies in areas aligned with Takeda's R&D pillars: Oncology, Rare Genetics & Hematology, Neuroscience and Gastrointestinal and Inflammation'. The takedaventures.com domain redirects to this page, which does not list portfolio companies, so no oncology portfolio examples are cited.
Headquarters
Cambridge, MA, US
Type
Founded
2001
Portfolio (0)
Filter the startups tableNo OnCo company names this investor yet. Portfolio links are declared on the startup record (`investors`), so adding one there lists it here.
Notes
top- Office location not stated on the fetched page; Cambridge, MA follows the task hint. No portfolio list available.